Browse Pharmatica main sections, topics, interview series, and company pages.
Type at least 2 characters to search
11 Clinical Trials Defining Pharmaceutical Strategy in 2026
We've mapped the competitive, regulatory, and commercial stakes of the top 11 clinical trials that have defined pharma strategy so far in 2026.
Eli Lilly and AtaiBeckley: AI and Psychedelic Biotech Converge
Eli Lilly's acquisition of Peter Thiel’s backed AtaiBeckley highlights growing investment in psychedelic biotech and the future of CNS drug discovery.
Psychedelic Drug Discovery Gets a New Preclinical Framework
Find out how psychedelic drug discovery is evolving through receptor pharmacology, behavioural science, and neuroplasticity to develop safer CNS therapeutics.
Google SensorFM: One Trillion Minutes of Wearable AI Data
Google SensorFM was pretrained on over one trillion minutes of wearable data. Discover what this AI foundation model could mean for digital health and pharma.
WHOOP x Natural Cycles: Wearable Health Data x Women’s Health
WHOOP and Natural Cycles show how wearable health data is moving into regulated digital health, creating new opportunities for women’s health and pharma.
Digital Measures in Clinical Trials: FDA vs EMA Pathways
Explore how novel digital measures gain regulatory acceptance in clinical trials, comparing FDA-structured pathways with EMA engagement-led frameworks.
No result found for
